EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review

Saifur R Chowdhury iD, Emily Sirotich, Gordon Guyatt, Daya Gill, Dimpy Modi, Laura M Venier, Syed Mahamad, Mahmudur Rahman Chowdhury, Kerolos Eisa, Carolyn E Beck, Vicky R Breakey, Kerstin de Wit und 34 weitere

European Journal of Haematology · 2025

DOI: 10.1111/ejh.14351 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Haematology, 2025. Verfasst von Saifur R Chowdhury und 45 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Canada. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Hemorrhage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Blood Services, Einstein Foundation Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Evidence‐based protocols for managing bleeding emergencies in patients with immune thrombocytopenia (ITP) are lacking. We conducted a systematic review of treatments for critical bleeding in patients with ITP.

Methods

We included all study designs and extracted data in aggregate or individually for patients who received one or more interventions and for whom any of the following outcomes were reported: platelet count response, bleeding, disability, or death.

Results

We identified 49 eligible studies reporting 112 critical bleed patients with ITP, including 66 children (median age, 10 years), 36 adults (median age, 41.5 years), and 10 patients with unreported age. Patients received corticosteroids ( n = 67), IVIG ( n = 49), platelet transfusions ( n = 41), TPO‐RAs ( n = 17), and splenectomy ( n = 28) either alone or in combination. Studies reported 29 different treatment combinations, the 5 most common were corticosteroids, platelet transfusion and splenectomy ( n = 13), corticosteroids and IVIG ( n = 13), or splenectomy alone ( n = 13); IVIG alone ( n = 11); and corticosteroids, IVIG and TPO‐RA ( n = 8). Mortality among patients with critical bleeds in ITP was 30.6% for adults and 19.7% for children.

Conclusions

The effects of individual treatments on patient outcomes were uncertain due to very low‐quality evidence. There is a need for a standardized approach to the treatment of ITP critical bleeds. Systematic Review Registration CRD42020161206.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicHemorrhageHumansTreatment OutcomeSplenectomyDisease ManagementImmunoglobulins, IntravenousCombined Modality TherapyAdultPlatelet TransfusionAdrenal Cortex HormonesChild

Stichwörter der Autor:innen

critical bleedingemergency managementimmune thrombocytopeniamajor bleedingthrombocytopenia

Substanzen

Immunoglobulins, IntravenousAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Canada.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
  • Department of Medicine, McMaster University, Hamilton, Canada.
  • MAGIC Evidence Ecosystem Foundation, Oslo, Norway.
  • Department of Public Health, North South University, Dhaka, Bangladesh.
  • Division of Paediatric Medicine, Department of Paediatrics, the Hospital for Sick Children, University of Toronto, Toronto, Canada.

ORCID-Profile: Saifur R Chowdhury

Förderung

  • CIHR
  • Canadian Blood Services
  • Einstein Foundation Berlin
  • Canadian Institutes of Health Research
  • Einstein Stiftung Berlin

Zitieren

APA

Chowdhury, S. R., Sirotich, E., Guyatt, G., Gill, D., Modi, D., Venier, L. M., Mahamad, S., Chowdhury, M. R., Eisa, K., Beck, C. E., Breakey, V. R., de Wit, K., Porter, S., Webert, K. E., Cuker, A., O'Connor, C., -DiRaimo, J. M., Yan, J. W., Manski, C., …, & Arnold, D. M. (2025). Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review. European Journal of Haematology. https://doi.org/10.1111/ejh.14351

Vancouver

Chowdhury SR, Sirotich E, Guyatt G, Gill D, Modi D, Venier LM, et al. Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review. European Journal of Haematology. 2025. doi:10.1111/ejh.14351

BibTeX
@article{Chowdhury2025,
  author = {Chowdhury, Saifur R and Sirotich, Emily and Guyatt, Gordon and Gill, Daya and Modi, Dimpy and Venier, Laura M and Mahamad, Syed and Chowdhury, Mahmudur Rahman and Eisa, Kerolos and Beck, Carolyn E and Breakey, Vicky R and de Wit, Kerstin and Porter, Stephen and Webert, Kathryn E and Cuker, Adam and O'Connor, Clare and -DiRaimo, Jennifer MacWhirter and Yan, Justin W and Manski, Charles and Kelton, John G and Kang, Matthew and Strachan, Gail and Hassan, Ziauddin and Pruitt, Barbara and Pai, Menaka and Grace, Rachael F and Paynter, Dale and Charness, Jay and Cooper, Nichola and Fein, Steven and Agarwal, Arnav and Nazaryan, Hasmik and Siddiqui, Ishaq and Leong, Russell and Pallapothu, Sushmitha and Wen, Aaron and Xu, Emily and Liu, Bonnie and Shafiee, Amirmohammad and Rathod, Preksha and Kwon, Henry and Dookie, Jared and Zeraatkar, Dena and Thabane, Lehana and Couban, Rachel and Arnold, Donald M},
  title = {Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review},
  journal = {European Journal of Haematology},
  year = {2025},
  doi = {10.1111/ejh.14351}
}
Kostenlos starten →